↓ Skip to main content

Dove Medical Press

Article Metrics

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2021
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
41 Mendeley
Title
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
Published in
Therapeutics and Clinical Risk Management, November 2021
DOI 10.2147/tcrm.s330813
Pubmed ID
Authors

Toussaint Rouamba, Houreratou Barry, Espérance Ouédraogo, Marc Christian Tahita, Nobila Valentin Yaméogo, Armel Poda, Eric Arnaud Diendéré, Abdoul-Salam Ouedraogo, Innocent Valea, Amariane M Koné, Cherileila Thiombiano, Isidore Traoré, Zekiba Tarnagda, Serge Aimé Sawadogo, Zakaria Gansané, Yibar Kambiré, Idrissa Sanou, Fatou Barro-Traoré, Maxime K Drabo, Halidou Tinto

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 7%
Student > Master 3 7%
Librarian 1 2%
Student > Doctoral Student 1 2%
Professor 1 2%
Other 3 7%
Unknown 29 71%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Environmental Science 2 5%
Chemical Engineering 1 2%
Unspecified 1 2%
Business, Management and Accounting 1 2%
Other 4 10%
Unknown 30 73%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2021.
All research outputs
#20,060,352
of 22,551,053 outputs
Outputs from Therapeutics and Clinical Risk Management
#1,138
of 1,257 outputs
Outputs of similar age
#358,032
of 427,761 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 2 outputs
Altmetric has tracked 22,551,053 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,257 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,761 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.